Table 1.
Baseline patient characteristics
| Intervention group | Control group | P value* | |
| Age (years) | 55.5±8.4 | 54.7±13.3 | 0.86 |
| Male | 15 | 7 | |
| Body surface area (m2) | 2.06±0.25 | 1.94±0.24 | 0.24 |
| Systolic blood pressure (mm Hg) | 130±15 | 137±13 | 0.24 |
| Diastolic blood pressure (mm Hg) | 81±12 | 75±15 | 0.28 |
| Heart rate | 66.5±16.3 | 65.1±11.5 | 0.81 |
| PCr/ATP ratio | 1.27±0.44 | 1.51±0.82 | 0.36 |
| NYHA | 14 | 7 | |
| NYHA II | 6 | 3 | |
| EF (%) | 69.0±6.8 | 69.8±8.3 | 0.79 |
| Mass/BSA (g/m2) | 73.5±20.0 | 79.8±18.6 | 0.43 |
*An expanded version of this table is available in the online supplemental table S2.
BSA, body surface area; EF, ejection fraction; NYHA, New York Heart association classification; PCr/ATP, myocardial phosphocreatine/adenosine triphosphate.